Biological assessment of Coccinia grandis leaf and Lupeol against β-lactam resistant Klebsiella pneumoniae through integrated in-silico and in-vitro studies
Open Access
- 27 February 2026
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
The current study investigated a detailed account of phytocompounds within Coccinia grandis using GC-MS coupled with high-performance liquid chromatography. An in-silico approach was employed to gain insight into the inhibitory mechanism of Lupeol on Klebsiella pneumoniae. The molecular dynamics simulations were conducted over 100 ns to investigate the stability of metallo-β-lactamase with Lupeol, Imipenem (IPM), and Meropenem (MRP). We meticulously explored the antimicrobial activities of the crude extract of C. grandis leaves (CGL) and Lupeol against carbapenem-resistant K. pneumoniae. Additionally, cellular disruption activity was verified using a scanning electron microscope to better understand the antimicrobial activity of Lupeol. The computed free binding energy evaluated for Lupeol was − 92.380 ± 2.261 kJ/mol. This substantial negative value suggested the robust inhibitory potential of Lupeol, indicating a strong and stable interaction between Lupeol and target protein gold-bound NDM-1. Furthermore, the in-vitro antimicrobial activity of CGL and Lupeol were compared with standard antibiotics; MRP and IPM through the disc diffusion method. The zone of inhibition, and minimum inhibitory concentration, were found to be 23 ± 0.57 and 0.02 ± 0.01 mg/ml for Lupeol, 14.33 ± 0.58 mm and 0.03 ± 0.01 mg/ml for CGL. The ZOI of 12.67 ± 0.58 mm for IPM and 12.33 ± 0.58 mm for MRP was observed whereas 0.13 ± 0.06 mg/ml and 0.17 ± 0.06 mg/ml of MIC was determined for IPM and MRP respectively. Furthermore, the mechanism of action of Lupeol demonstrated significant activity in cell wall disruption assay and NDM-1 enzyme inhibition assay. Moreover, Lupeol also showed apoptotic activity against various cancer cell lines and no cytotoxic effect against healthy cell line. This study suggested Lupeol as an alternative natural therapeutic compound as an inhibitor of β-lactam resistant K. pneumoniae.Keywords
Funding Information
- Siksha 'O' Anusandhan Deemed to be University
This publication has 92 references indexed in Scilit:
- Nonsynonymous mutations in VEGF receptor binding domain alter the efficacy of bevacizumab treatmentJournal of Cellular Biochemistry, 2024
- Phytochemistry, Pharmacology and Toxicity of Medicinal Plants2021
- In Silico Approach in Drug Design and Drug Discovery: An Update2021
- Antibacterial, Antifungal, and Antiviral Properties of Medical Plants2019
- In silico analysis and molecular dynamics simulation of human superoxide dismutase 3 (SOD3) genetic variantsJournal of Cellular Biochemistry, 2018
- Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016Intensive Care Medicine, 2017
- Head and neck cancers manifested as deep neck infectionEuropean Archives of Oto-Rhino-Laryngology, 2011
- Improved side‐chain torsion potentials for the Amber ff99SB protein force fieldProteins: Structure, Function, and Bioinformatics, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- LINCS: A linear constraint solver for molecular simulationsJournal of Computational Chemistry, 1997